top of page
Life-Cycle Insights Logo


Pharmaceuticals  |  Biotech  |  Biosimilars

IPD's Life-Cycle Insights subscription provides unmatched visibility into the life cycle of drugs and biologics, from early-stage pipeline assets to mature, established products. 

  • Brand, generic, and biosimilar launch tracking

  • Loss-of-exclusivity insight, timing, and analytics

  • Innovative drug pipeline tracking

  • Litigation analysis and forecasted litigation outcomes

  • Regulatory impacts

Our team of former patent litigators, former Federal Circuit Clerks, PhD scientists, and patent researchers analyze public and proprietary data to provide summarized, comprehensive, strategic, and tactical analysis and insights. 

Our subscribers gain around-the-clock access to IPD's proprietary web-based platform with real-time email alerts and expert consultations.

  • Data and analysis covering thousands of drugs and biologics in all major disease states and indications

  • Brand, generic, and biosimilar launch tracking tools to monitor new market entrants to the market and their impact on product pricing

  • Loss-of-exclusivity forecasts, patent information, regulatory data, generic-filer information, API complexity information, disease-area overviews, competitive intelligence, and drug pipelines up to
    10 years in the future

  • Information on pending litigation and regulatory proceedings such as court cases, hearings, and oppositions that affect launch timing, direct vs. indirect competitors, and marketplace shifts

bottom of page